Table 3. Factors associated with liver MRI–CT image fusion discrepancy >5 mm of any validation point.
Variables | No. of patients | No. of patients with fusion discrepancy >5 mm (%) | p-value |
Sex | |||
Male | 47 | 24 (51.0) | 0.672 |
Female | 6 | 4 (66.7) | |
ECOG performance | |||
0–1 | 46 | 24 (51.1) | 0.234 |
≥2 | 7 | 4 (57.1) | |
Child–Pugh classification | |||
A | 43 | 21 (48.8) | 0.172 |
B–C | 10 | 7 (70.0) | |
LN metastasis | |||
Positive | 8 | 4 (50.0) | 1.000 |
Negative | 45 | 24 (53.3) | |
Distant metastasis | |||
Positive | 7 | 2 (28.6) | 0.234 |
Negative | 46 | 26 (56.5) | |
Tumour size | |||
<10 cm | 41 | 21 (51.2) | 0.750 |
≥10 cm | 12 | 7 (58.3) | |
Number of tumours | |||
Solitary | 25 | 14 (56.0) | 0.785 |
Multiple | 28 | 14 (50.0) | |
Ascites | |||
Positive | 12 | 10 (83.3) | 0.022 |
Negative | 39 | 18 (43.9) | |
Pulmonary disease | |||
Positive | 8 | 7 (87.5) | 0.053 |
Negative | 45 | 21 (46.7) | |
Ascites or pulmonary disease | |||
Positive | 18 | 16 (88.9) | <0.001 |
Negative | 35 | 12 (34.3) |
ECOG, Eastern Cooperative Oncology Group; LN, lymph node.